Yes, why not market sensitive? Just a quick search below comes up with 4 concrete examples of Orphan Drug Designation being granted and EACH ONE IS MARKET SENSITIVE as marked by the ASX. I could go on because there are plenty more but why the inconsistency. So what does Orphan Drug status do, it usually means tax credits for trials, a market exclusive period and less or no fees throughout the drug approval process.
Mesoblast MSB 15/02/24, Neuren NEU 3/9/21, Noxopharm NOX 4/10/23, Argenica AGN 15/11/23 All market sensitive but not CUV 29/4/24?
Yes, why not market sensitive? Just a quick search below comes...
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.58 |
Change
0.420(2.77%) |
Mkt cap ! $778.1M | |||
| Open | High | Low | Value | Volume |
| $15.08 | $15.60 | $15.08 | $745.2K | 48.26K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 80 | $15.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.58 | 146 | 5 |
View Market Depth
| Last trade - 12.30pm 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$15.53 |
Change
0.420 ( 2.88 %) |
||||
| Open | High | Low | Volume | ||
| $15.30 | $15.59 | $15.30 | 3595 | ||
| Last updated 12.47pm 14/05/2024 ? | |||||
| CUV (ASX) Chart |